Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Colucci

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Circulation Research|May 26, 2001
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontinN A Trueblood, Z Xie, C Communal, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
The New England Journal of Medicine|July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study GroupW S Colucci, U Elkayam, D P Horton, et al.
Circulation|November 1, 2000
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study InvestigatorsM T Slawsky, W S Colucci, S S Gottlieb, et al.
Circulation|February 18, 1997
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure ResearchJ N Cohn, M R Bristow, K R Chien, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Circulation|December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study GroupW S Colucci, M Packer, M R Bristow, et al.
Circulation|December 1, 1996
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and ExerciseM Packer, W S Colucci, J D Sackner-Bernstein, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Circulation Research|May 26, 2001
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontinN A Trueblood, Z Xie, C Communal, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
The New England Journal of Medicine|July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study GroupW S Colucci, U Elkayam, D P Horton, et al.
Circulation|November 1, 2000
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study InvestigatorsM T Slawsky, W S Colucci, S S Gottlieb, et al.
Circulation|February 18, 1997
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure ResearchJ N Cohn, M R Bristow, K R Chien, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Circulation|December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study GroupW S Colucci, M Packer, M R Bristow, et al.
Circulation|December 1, 1996
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and ExerciseM Packer, W S Colucci, J D Sackner-Bernstein, et al.
Pageof 17